OPI 409 (Chlordiazepoxide and Clidinium 5 mg / 2.5 mg)
Pill imprint OPI 409 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.
Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- OPI 409
- 5 mg / 2.5 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Oceanside Pharmaceuticals, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Green No. 3
More about chlordiazepoxide/clidinium
- Chlordiazepoxide and clidinium
- Chlordiazepoxide and clidinium (Advanced Reading)
- Other brands: Librax
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.